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Abstract. Thirty-two patients (10 male, 22 female; age
37-82 years) undergoing maintenance haemodialysis or
haemofiltration were studied by means of Holter device
capable of simultaneously analysing rhythm and ST-
changes in three leads. Twenty-five patients were on
haemodialysis, seven on haemofiltration, mean duration
of haemodialysis/haemofiltration being 3.4 + 3 years.
Incidence of ventricular tachycardia was low, being
detected only in 1 of 32 patients. Ventricular premature
beats in excess of 10/h during a period of 2 h were found
in 8 of 32 patients and 100 supraventricular premature
beats for 2 h or more in 4 of 32 patients. Both ventricular
premature beats and supraventricular premature beats
were most frequently recorded during the last hour of
haemodialysis/haemofiltration. ECG signs of ischaemia
were detected in eight patients, four of whom were
asymptomatic. Ischaemia also occurred predominantly
during the last hour of haemodialysis/haemofiltration.
Two symptomatic patients displayed neither arrhythmias
nor ST-changes while being monitored. The study shows
that silent ischaemia and arrhythmias in patients under-
going chronic haemodialysis/haemofiltration may not
be infrequent. Recognition of these events could be of
importance in the management of these patients.
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Introduction
About 50% of patients on chronic haemodialysis die
from cardiovascular disease, 16% dying suddenly [1]. The
incidence of cardiac arrhythmias during haemodialysis
and haemofiltration has recently been investigated exten-
sively. Several authors found the incidence of complex
cardiac arrhythmias to be correlated closely to the
duration of haemodialysis/haemofiltration [2-4]. In the
field of cardiology, asymptomatic myocardial ischaemia
has recently become a topic of major interest. It is now
evident that patients with silent ischaemia are also at
greater risk of coronary events and sudden death [5].
Because chronic renal failure contributes to a higher
morbidity due to coronary artery disease, patients with
chronic renal diseases should be examined for signs of
coronary artery disease in order to treat ischaemia and
complex ventricular arrhythmias [6-12]. New Holter
technology with the possibility of ST analysis provides
the tool to study these problems during haemodialysis/
haemofiltration.
The aim of our study was therefore, first, to show
the practicability and efficacy of continuous rhythm and
ST analysis, and second, to evaluate the incidence of
arrhythmia and ischaemic events during haemodialysis/
haemofiltration as well as their correlation to pre-existent
coronary artery disease.
Patients and Methods
Thirty-two patients with a median age of 63 years (range
37-82 years, 10 male, 22 female) who had been on main-
tenance haemodialysis/haemofiltration for 3.4 + 3 years
were studied. During haemodialysis/haemofiltration
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Holter recordings with CCU-Compas were performed in
three leads with on-line analysis of arrhythmias and ST
changes. The arrhythmias were differentiated by a three-
channel comparative algorithm in supraventricular and
ventricular aetiology, and registered. Algorithm for ST
analysis takes into account ST depression in 0.1 mV below
zero, simultaneously assessing slope and a duration of at
least 40 beats. QRS duration must be less than 120 msec.
ST depression is reported to the nearest mm, and duration
is given to the nearest minute. To eliminate false positive
results only ST depression of 2 or more mm was taken
to indicate ischaemia in our study. Heart rate at the
beginning and the end of the episode was documented. A
report of the Holter study was plotted at the end of
the recording for arrhythmias and ST analysis. The
registration was then evaluated independently by two
cardiologists. Discrepancies were discussed by reviewing
in order to reach a final evaluation by consensus. Figure 1
shows a typical example of an ischaemic event in a 75-
year-old female patient during haemodialysis.
mV
patients with documented Q-wave infarction in the ECG,
scars or ischaemia in thallium or technetium scans, or
presence of significant coronary stenosis by angiography.
Fisher's exact test was used for statistical evaluation.
Results
1. Cardiac Arrhythmias
Only one of 32 patients had ventricular tachycardias.
Frequent ventricular premature beats during 2h,
defined as 10 or more ventricular premature beats per
hour, were found in 8 of 32 patients during haemodialysis/
haemofiltration. Ventricular premature beats increased
significantly in frequency during the last 2 h of haemo-
dialysis/haemofiltration.
Supraventricular premature beats of 100/h or more
during 2 h could be detected in four of the 32 patients.
Similarly to ventricular premature beats, supraventri-
cular premature beats also occurred more frequently
during the last 2 h of haemodialysis/haemofiltration. No
correlation between arrhythmias and presence of proven
coronary artery disease was found (P > 0.2).
Fig. 1. Example of an ischaemic episode during haemodialysis in a 75-
year-old female patient. On the left side is the ECG tracing at the begin-
ning of haemodialysis, and on the right is shown the tracing of the same
patient during asymptomatic ischaemia during haemodialysis.
The single patient on digitalis who also developed clear
cut ischaemic changes during Holter recording was
excluded from the statistical analysis. Five of eight
patients who developed ECG signs of ischaemia did not
receive cardioactive drugs, while three patients with
ischaemia had anti-ischaemic treatment either with cal-
cium antagonists, nitrates, or beta-blockers. Coronary
artery disease was assumed to be present in eight of the 32
2. Ischaemia
Eight of 32 patients developed ECG signs of ischaemia.
Only four of these eight patients were symptomatic. The
ST depression lasted from 40 to 90min and occurred
mostly during the last 2 h. No patient with ST depression
had previously known objective signs for coronary artery
disease. Nevertheless a statistical difference between
patients with and without proven coronary artery
disease was not found (P>0.l). Two additional patients
who developed symptoms suggestive of coronary artery
disease displayed neither arrhythmias nor ischaemic ST
changes.
3. ECG at Rest
Nineteen of the 32 patients had an abnormal ECG at rest.
The most frequent abnormality was left ventricular
hypertrophy, followed by pathological Q-waves, atrial
fibrillation and conduction blocks. Twelve of these
patients with a pathological ECG at rest showed either
significant ST depression, arrhythmias, or both. On the
other hand only four of the 13 patients with normal ECG
at rest showed significant ST depression or arrhythmias.
The correlation between abnormal ECG findings at rest
and occurrence of arrhythmias and/or ST depression




Our study shows that simple ventricular premature beats
occur frequently during haemodialysis/haemofiltration
(25%), especially during the last 2h, indicating that
dialysis has an arrhythmogenic effect. We did not observe
a burst of complex ventricular arrhythmias, as recently
published from a multicentre, cross-sectional Italian
study [1], which describes ventricular arrhythmias in
79% with 21% Lown class 4A or B from the 3rd hour
during haemodialysis up to at least 5 h after dialysis. ST
depression, indicative of ischaemic episodes, could be
demonstrated in a quarter of our patients, and occurred
predominantly in the last 2 h of haemodialysis or haemo-
filtration. Fifty per cent of all patients remained entirely
asymptomatic.
No observation has been published demonstrating
myocardial ischaemia or ischaemia-like ST changes
during haemodialysis/haemofiltration. Such phenomena
could be due to electrolyte disturbance during the end
phase of treatment, as demonstrated for arrhythmias
in hypokalaemic and hypomagnesaemic states due to
diuretic therapy or during the acute phase of myocardial
infarction [14-15]. Another explanation could be volume
depletion as a result of ultrafiltration, which is more likely
to occur during the last hours of the procedure [16].
The search for silent ischaemic events and arrhythmias
is of importance because of the high prevalence of
coronary artery disease (up to 64%) in patients with
end-stage renal disease [17]. The high proportion of
asymptomatic patients in our study (50%) and in others
demonstrates the low sensitivity of clinical symptoms in
patients with coronary artery disease [18-20]. Ischaemia
can be proven either by stress ECG, thallium or techne-
tium scintigraphy, or Holter monitoring. Because stress
testing is often not feasible in patients with end-stage renal
disease, Holter ST monitoring provides a good alternative
tool and allows long-term analysis during the whole
haemodialysis/haemofiltration session. Furthermore, this
method helps to separate symptomatic patients without
coronary artery disease from patients with ischaemia
and atypical chest pain. Patients with pathological
resting ECG might be the first to profit from Holter
ST/arrhythmia investigation, because they tend to have
more ischaemic and arrhythmic episodes.
The study shows that silent ischaemia and arrhythmias
are likely to occur in patients undergoing chronic haemo-
dialysis/haemofiltration. Recognition of these events
could be of importance in the management of these
patients.
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